Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
09/29/2011 | US20110236259 Sample analyzer |
09/29/2011 | US20110235021 Method of detecting an emulsion in brine |
09/29/2011 | US20110233422 Particle or cell analyzer and method |
09/29/2011 | US20110233075 Nanostructured microelectrodes and biosensing devices incorporating the same |
09/29/2011 | US20110233074 Biosensors and Methods of Preparing Same |
09/29/2011 | US20110233073 Biosensor for detecting anti-hiv antibodies |
09/29/2011 | US20110233059 Microfluid sensor |
09/29/2011 | US20110232769 Method of Stabilizing Constant-Temperature Bath |
09/29/2011 | US20110232398 Method for automatically identifying a material or an object |
09/29/2011 | US20110232394 Method of measuring stress history and composite material containing cement as main component |
09/29/2011 | US20110232372 Sample analyzer and reagent information obtaining method |
09/29/2011 | US20110232368 Pressurized and heated testing chamber |
09/29/2011 | US20110232356 Electrophoretic Analysis System Having In-Situ Calibration |
09/29/2011 | DE112009002256T5 Inspektion einer Pipeline Inspection of a pipeline |
09/29/2011 | DE112009001010T5 Biologisches Verfahren zur in-vivo-Detektion von Molekülen, die die Zellmigration beeinflussen Biological process for the in vivo detection of molecules which affect the cell migration |
09/29/2011 | DE102010013082A1 Device for analyzing decomposition process of samples during inorganic raw material treatment, has sample receiving unit connected with balancing unit for obtaining weight of sample receiving unit |
09/29/2011 | CA2794551A1 Substitute therapy for glucocorticoids |
09/29/2011 | CA2794255A1 Protein and gene biomarkers for rejection of organ transplants |
09/29/2011 | CA2794234A1 Detection device for detecting analytes in liquid specimen |
09/29/2011 | CA2794088A1 Immunoassays, methods for carrying out immunoassays, immunoassay kits and method for manufacturing immunoassay kits |
09/29/2011 | CA2794021A1 Hbf and a1m as early stage markers for preeclampsia |
09/29/2011 | CA2793877A1 Mutations associated with cystic fibrosis |
09/29/2011 | CA2793735A1 Early detection of recurrent breast cancer using metabolite profiling |
09/29/2011 | CA2793216A1 Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics |
09/29/2011 | CA2790416A1 Methods and materials for detecting colorectal neoplasm |
09/29/2011 | CA2788760A1 Ltbp2 as a biomarker for renal dysfunction |
09/29/2011 | CA2788636A1 Il-6 detection based early diagnosis and prediction of systemic inflammatory response syndrome and sepsis in asymptomatic patients |
09/29/2011 | CA2767182A1 Droplet generation for droplet-based assays |
09/29/2011 | CA2767114A1 Droplet transport system for detection |
09/28/2011 | EP2369517A2 Methods for the identification of microrna and their applications in research and human health |
09/28/2011 | EP2369350A2 Use of precursors of tachykinins and/or their fragments in medical diagnostic |
09/28/2011 | EP2369349A2 Non-invasive in vitro method to detect transitional cell carcinoma of the bladder |
09/28/2011 | EP2369348A1 Biomarkers for Alzheimer's disease |
09/28/2011 | EP2369347A1 Biomarkers for Alzheimer's disease |
09/28/2011 | EP2369346A2 Means and method for diagnosing diabetes |
09/28/2011 | EP2369345A1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
09/28/2011 | EP2369344A1 Structural model of G protein-coupled receptor and method for designing ligand capable of binding to G protein-coupled receptor using the structural model |
09/28/2011 | EP2369343A1 Device and method for manipulating or examining a liquid sample |
09/28/2011 | EP2369342A2 Fluorescent silica-based nanoparticles |
09/28/2011 | EP2369341A2 Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual |
09/28/2011 | EP2369340A1 Evaluating the modulus of elasticity of wooden elements at a reference temperature |
09/28/2011 | EP2369339A1 Electronic device for monitoring the physical characteristics of concrete castings |
09/28/2011 | EP2369338A2 Calorific value calculation formula creation system, method of creating calorific value calculation formula, calorific value measurement system and method of measuring calorific value |
09/28/2011 | EP2369337A2 Calorific value calculation formula creation system, method of creating calorific value calculation formula, calorific value measurement system, and method of measuring calorific value |
09/28/2011 | EP2369336A1 Method and apparatus for determining whether an egg contains a live embryo |
09/28/2011 | EP2369335A1 Device for determining the mercury content of a sample |
09/28/2011 | EP2369332A1 Hybrid film type sensor |
09/28/2011 | EP2369015A1 Assay for localised detection of analytes |
09/28/2011 | EP2369014A1 Compositions and methods for characterizing, regulating, diagnosing and treating cancer |
09/28/2011 | EP2369006A1 Covalent tethering of functional groups to proteins |
09/28/2011 | EP2368997A2 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368996A2 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368995A2 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368994A2 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368993A2 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368992A2 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368991A2 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368990A1 Method for isolation of soluble polypeptides |
09/28/2011 | EP2368912A1 Regulators of NFAT |
09/28/2011 | EP2368907A2 Anti-Abeta antibodies and their use |
09/28/2011 | EP2368906A1 Fas associated factor 1 |
09/28/2011 | EP2368902A2 Insulin and IGF-1 receptor agonists and antagonists |
09/28/2011 | EP2368637A1 Microfluidic multiple compartment measuring chamber assembly |
09/28/2011 | EP2368636A2 Systems and methods for rapidly changing the solution environment around sensors |
09/28/2011 | EP2368635A2 Systems and methods for rapidly changing the solution environment around sensors |
09/28/2011 | EP2368565A1 Enrichment of pre-beta high density lipoproteins |
09/28/2011 | EP2368431A1 Immunostimulatory G,U-containing oligoribonucleotides |
09/28/2011 | EP2368124A1 Method of determining pegylated blood coagulation factor activity in a silica-based activated partial thromboplastin time assay |
09/28/2011 | EP2368123A1 In-process control in a method for producing epo |
09/28/2011 | EP2368122A1 Method for detecting a prion infection |
09/28/2011 | EP2368121A1 Method to select animals with a high capacity of embryo production |
09/28/2011 | EP2368120A1 Peptide linkers for effective multivalent peptide binding |
09/28/2011 | EP2368119A1 Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers |
09/28/2011 | EP2368118A1 Biomarkers for inhibitors with anti-angiogenic activity |
09/28/2011 | EP2368117A1 Method for detection of autoimmune diseases |
09/28/2011 | EP2368116A1 Biosensor system for actuating magnetic particles |
09/28/2011 | EP2368115A1 Analyte detection assay |
09/28/2011 | EP2368114A2 Prediction and prevention of preeclampsia |
09/28/2011 | EP2368113A1 Biomarkers for the diagnosis of renal allograft and kidney status |
09/28/2011 | EP2368112A1 Liver cell toxicity assay |
09/28/2011 | EP2368111A1 Honey analysis |
09/28/2011 | EP2368110A1 System and apparatus for measurement and mapping of pollutants |
09/28/2011 | EP2368109A1 Gas sensor assembly containing a gasfet sensor and a filter element for degrading ozone |
09/28/2011 | EP2367957A1 Methods for estimating target nucleic acid in a sample prior to amplification |
09/28/2011 | EP2367939A1 Methods for diagnosing or treating prostate cancer |
09/28/2011 | EP2367930A1 Cell separation technique |
09/28/2011 | EP2367851A1 Antibody-targeted carrier for contrast agents |
09/28/2011 | EP2367841A2 Peptide tag and uses thereof |
09/28/2011 | EP2367633A1 Assay device and method for performing biological assays |
09/28/2011 | EP2367632A1 Device and analyzing system for conducting agglutination assays |
09/28/2011 | EP2367565A1 Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma. |
09/28/2011 | EP2240775B1 Immunomagnetic capture and imaging of biological targets |
09/28/2011 | EP2154536B1 Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes |
09/28/2011 | EP2088203B1 Method for screening allergic disease-related molecule and cell line to be used in the method |
09/28/2011 | EP2027283B1 Method for screening agent with angiogenic-modulating activities using teleost embryo |
09/28/2011 | EP1945201B1 Calcium receptor activator |
09/28/2011 | EP1937827B1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
09/28/2011 | EP1864131B1 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
09/28/2011 | EP1854883B1 Assist probes and method of using the same |
09/28/2011 | EP1790982B1 Multilayer analysis element |